Relief Bounce, Softer Open: Why Friday Still Looks Like a Headline-Driven Market

Thursday’s session ended with a familiar pattern for this market. Stocks spent most of the day under pressure as oil surged on fresh Middle East energy disruptions, then staged a late rebound after Israeli Prime Minister Benjamin Netanyahu suggested the war could end “a lot faster than people think.” Even with that recovery, all three major U.S. indexes still finished lower, which tells you the bigger story. Investors were willing to buy the dip, but not yet willing to trust the bounce.

By Friday morning, that caution was showing up again in actual trading, not just futures. Shortly after the opening bell, the Dow was down about 0.4%, or roughly 200 points, while the S&P 500 and Nasdaq were each off about 0.3%. At the same time, oil had come off its panic highs, with Brent near $107 a barrel and WTI around $95, but those are still levels that keep inflation, rates, and consumer pressure firmly in the conversation.

That is the setup for the day. The market is trying to balance two competing ideas at once. One is that Thursday’s late reversal may have been the first sign that investors are getting more comfortable with the conflict. The other is that nothing about the underlying situation actually looks settled, and the Fed’s posture has become less forgiving as energy prices threaten to feed inflation again. Reuters reported that traders have already pushed expectations for the next Fed cut out to 2027. That is not the kind of backdrop that makes rallies easy to trust.

Stock of Interest Today: AtaiBeckley (ATAI)

If most of the market is being yanked around by oil, war headlines, and shifting rate expectations, AtaiBeckley offers a very different kind of story. The company is a clinical-stage biotech focused on mental health treatments, and its lead candidate, BPL-003, is being developed for treatment-resistant depression. Earlier this month, the company said BPL-003 remains on track to enter Phase 3 in the second quarter of 2026 after a successful end-of-phase-2 meeting with the FDA. It also said the therapy holds Breakthrough Therapy designation, which gives the program a clearer regulatory profile than many early-stage biotech hopefuls enjoy.

The clinical case is the reason the stock keeps showing up on watchlists. AtaiBeckley has pointed to Phase 2b results showing rapid antidepressant effects by Day 2 and durable improvements through eight weeks, with the company framing BPL-003 as a treatment designed to deliver meaningful effects from a single dose with a relatively short in-clinic experience. In a market where investors increasingly want real, visible catalysts, that sort of timeline matters. This is not a vague platform story. It is a product story with a defined next step.

The balance sheet also helps. AtaiBeckley reported $220.7 million in cash, cash equivalents, and short-term securities at year-end 2025, along with no current or long-term debt, and said that capital should fund operations into early 2029. That does not remove execution risk, because biotech never works that way, but it does reduce the financing overhang that often hangs over development-stage names.

There is still a real valuation debate here. A recent Seeking Alpha analysis noted that the stock was trading at roughly 5.9 times book value, above a cited peer median of 2.7, which suggests the market is already assigning some premium to the BPL-003 story. At the same time, the underlying opportunity is not trivial. One industry forecast projects the treatment-resistant depression market could grow to $4.8 billion by 2035, which helps explain why investors are willing to pay up for a company with a plausible shot at a differentiated product.

Current price: $3.57Analyst expectation: $14.14

Five Market Themes

This morning’s tape looks messy because several sources of volatility are hitting at once. There is the oil story, the geopolitical story, the Fed story, the options-expiration story, and the simple fact that it is Friday in a market that has learned not to feel too brave heading into a weekend. None of those factors would be especially comfortable on their own. Together, they create exactly the kind of market that can reverse hard, often, and for reasons that look obvious only in hindsight.

That is why the most useful way to frame the session is not as a binary question about whether stocks are up or down at a given minute. It is about which forces are most likely to shape the rest of the day, and which ones the market still seems to be underestimating.

1) Relief talk is not the same thing as resolution

Netanyahu’s comments helped spark Thursday’s late rebound, but the market’s behavior since then suggests traders are treating those remarks as a temporary sentiment boost, not a durable signal that the conflict is winding down. Reuters reported that the war has moved into its fourth week, and broader reporting shows that attacks on energy infrastructure and shipping routes remain central to the risk picture. That is why Friday opened lower even after Thursday’s sharp reversal off the lows. The market heard the optimism. It just has not fully believed it.

2) Quadruple witching makes a jumpy market more erratic

Today is quadruple witching day, when stock index futures, stock index options, stock options, and single-stock futures all expire together. In calm markets, that can already produce heavy volume and awkward price action. In a market this headline-sensitive, it can amplify moves that have less to do with conviction than with mechanical repositioning. That means intraday swings may look dramatic without necessarily revealing anything durable about sentiment.

3) The Red Sea risk is not gone just because oil backed off its highs

Much of the focus remains on the Strait of Hormuz, but another route matters here too. RBC Capital Markets warned that if the Houthis enter the conflict more directly, even limited disruption around the Bab el-Mandeb Strait could materially change how traders think about global oil transport. Reuters has also reported that producers have been leaning harder on Red Sea alternatives as the Hormuz situation has deteriorated. In other words, one chokepoint is already stressed, and the market is still trying to price the risk that the backup route could become more dangerous too.

4) Oil’s retreat still leaves stocks with an inflation problem

The decline in crude from Thursday’s intraday extremes helped calm markets a bit, but it did not solve the core issue. Reuters reported Brent around $107 and WTI near $95 on Friday morning, both still elevated enough to keep inflation concerns alive. That matters because Thursday’s market weakness was not just about war risk in the abstract. It was about what higher energy prices mean for rate cuts, bond yields, margins, and consumer spending. Once oil gets this high, even a pullback can still leave the broader market in a worse place than it was before the spike began.

5) Friday carries its own risk premium now

There is also a simple behavioral pattern at work. Barron’s noted that recent Fridays have been especially difficult because investors do not want to head into a weekend overloaded with risk when the geopolitical backdrop can change while markets are closed. That does not guarantee a late-day selloff, but it does create a bias toward caution, especially in a market where every sharp rebound has recently had to prove itself all over again a few hours later.

Bottom Line

Thursday’s rebound was real, but Friday’s open is a reminder that it was not a clean turning point. Stocks are lower again after the bell, oil remains elevated even after easing, and the Fed backdrop has become less friendly just as geopolitical risk is making inflation harder to ignore. The market is not behaving like it has found clarity. It is behaving like it is trying to rent a little relief while staying ready for the next shock.

That is the core takeaway for today. This is still a market where price action can improve faster than conviction does. Until investors get something more concrete than a temporary dip in oil or a hopeful political remark, every bounce is likely to be treated as tactical first and durable second.

Sources:

Market Munchies and Mode Mobile communications are for informational purposes only, and are not a recommendation, solicitation, or research report relating to any investment strategy, security, or digital asset. All investments involve risk including the loss of principal and past performance does not guarantee future results.

Any information contained in this commentary does not purport to be a complete description of the securities, markets, or developments referred to in this material. The information has been obtained from sources considered to be reliable, but we do not guarantee that the foregoing material is accurate or complete. There is no guarantee that any statements or opinions provided herein will prove to be correct.